FBXO31 promotes cell proliferation, metastasis and invasion in lung cancer

American Journal of Cancer Research

Volumn 5, Issue 5, 2015, Pages 1814-1822

  Huang, Hai Li ^a   Jiang, Yun ^a   Wang, Ya Hong ^a   Chen, Ting ^a   He, Hui Juan ^a   Liu, Tie ^a,b   Yang, Teng ^a   Yang, La Wei ^a   Chen, Jie ^a   Song, Ze Qing ^a   Yao, Weimin ^a   Wu, Bin ^a   Liu, Gang ^a  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

^b XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

FBXO31; Invasion; Lung cancer; Metastasis; Tumor growth

Indexed keywords

EID: 85006207069     PISSN: None     EISSN: 21566976     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Velu TJ and Lowy DR. Proto-oncogene activation in lung cancer. N Engl J Med 1988; 318: 992.
2. Little CD, Nau MM, Carney DN, Gazdar AF and Minna JD. Amplification and expression of the c-myc oncogene in human lung cancer cell lines. Nature 1983; 306: 194-196.
3. Zhou Z, Hao Y, Liu N, Raptis L, Tsao MS and Yang X. TAZ is a novel oncogene in non-small cell lung cancer. Oncogene 2011; 30: 2181-2186.
4. Suzuki C, Takahashi K, Hayama S, Ishikawa N, Kato T, Ito T, Tsuchiya E, Nakamura Y and Daigo Y. Identification of Myc-associated protein with JmjC domain as a novel therapeutic target oncogene for lung cancer. Mol Cancer Ther 2007; 6: 542-551.
5. Regala RP, Weems C, Jamieson L, Khoor A, Edell ES, Lohse CM and Fields AP. Atypical protein kinase C iota is an oncogene in human non-small cell lung cancer. Cancer Res 2005; 65: 8905-8911.
6. Kabbout M, Garcia MM, Fujimoto J, Liu DD, Woods D, Chow CW, Mendoza G, Momin AA, James BP, Solis L, Behrens C, Lee JJ, Wistuba, II and Kadara H. ETS2 mediated tumor suppressive function and MET oncogene inhibition in human non-small cell lung cancer. Clin Cancer Res 2013; 19: 3383-3395.
7. Wang R, Wang ZX, Yang JS, Pan X, De W and Chen LB. MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14). Oncogene 2011; 30: 2644-2658.
8. Shimizu E and Sone S. Tumor suppressor genes in human lung cancer. J Med Invest 1997; 44: 15-24.
9. Kuramochi M, Fukuhara H, Nobukuni T, Kanbe T, Maruyama T, Ghosh HP, Pletcher M, Isomura M, Onizuka M, Kitamura T, Sekiya T, Reeves RH and Murakami Y. TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer. Nat Genet 2001; 27: 427-430.
10. Chen S, Xu Y, Chen Y, Li X, Mou W, Wang L, Liu Y, Reisfeld RA, Xiang R, Lv D and Li N. SOX2 gene regulates the transcriptional network of oncogenes and affects tumorigenesis of human lung cancer cells. PLoS One 2012; 7: e36326.
11. Kumar MS, Hancock DC, Molina-Arcas M, Steckel M, East P, Diefenbacher M, Armenteros-Monterroso E, Lassailly F, Matthews N, Nye E, Stamp G, Behrens A and Downward J. The GATA2 transcriptional network is requisite for RAS oncogene-driven non-small cell lung cancer. Cell 2012; 149: 642-655.
12. Kumar R, Neilsen PM, Crawford J, McKirdy R, Lee J, Powell JA, Saif Z, Martin JM, Lombaerts M, Cornelisse CJ, Cleton-Jansen AM and Callen DF. FBXO31 is the chromosome 16q24.3 senescence gene, a candidate breast tumor suppressor, and a component of an SCF complex. Cancer Res 2005; 65: 11304-11313.
13. Jia L and Sun Y. F-box proteins FBXO31 and FBX4 in regulation of cyclin D1 degradation upon DNA damage. Pigment Cell Melanoma Res 2009; 22: 518-519.
14. Santra MK, Wajapeyee N and Green MR. F-box protein FBXO31 mediates cyclin D1 degradation to induce G1 arrest after DNA damage. Nature 2009; 459: 722-725.
15. Shiloh Y. FBXO31: a new player in the ever-expanding DNA damage response orchestra. Sci Signal 2009; 2: pe73.
16. Vadhvani M, Schwedhelm-Domeyer N, Mukherjee C and Stegmuller J. The centrosomal E3 ubiquitin ligase FBXO31-SCF regulates neuronal morphogenesis and migration. PLoS One 2013; 8: e57530.
17. Silvers CR, Williams K, Salamone L, Huang J, Jordan CT, Zhou H and Palapattu GS. A novel in vitro assay of tumor-initiating cells in xenograft prostate tumors. Prostate 2010; 70: 1379-1387.
18. Kogo R, Mimori K, Tanaka F, Komune S and Mori M. FBXO31 determines poor prognosis in esophageal squamous cell carcinoma. Int J Oncol 2011; 39: 155-159.
19. Huang HL, Zheng WL, Zhao R, Zhang B and Ma WL. FBXO31 is down-regulated and may function as a tumor suppressor in hepatocellular carcinoma. Oncol Rep 2010; 24: 715-720.
20. Tomoya Sudo RK, Naohiro Nishida, Keisuke Takahahi, Genta Sawada, Masahisa Ishibashi, Junji Kurashige, Ryutaro Uchi, Tae Matsumura, Hiroki Ueo, Kousuke Mima. The Significance of the Expression of FBXO31 in Gastric Cancer. Journal of Cancer Therapy 2013; 4: 75-79.